Zobrazeno 1 - 10
of 235
pro vyhledávání: '"Knowles, MA"'
Thesis (M.Ed.(Educational Management, Law and Policy))-University of Pretoria, 2007.
Includes bibliographical references. Available on the Internet via the World Wide Web.
Includes bibliographical references. Available on the Internet via the World Wide Web.
Externí odkaz:
http://upetd.up.ac.za/thesis/available/etd-06042008-074812/
Autor:
Hurst, CD, Cheng, G, Platt, FM, Alder, O, Black, EVI, Burns, JE, Brown, J, Jain, S, Roulson, J, Knowles, MA
Pure squamous cell carcinoma (SCC) is the most common pure variant form of bladder cancer, found in 2–5% of cases. It often presents late and is unresponsive to cisplatin-based chemotherapy. The molecular features of these tumours have not been elu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::7270052d33dbe3e2364569ce73aee7b4
Publikováno v:
Matrix Biology Plus. 14:100109
Despite improvements in the understanding of disease biology, pancreatic ductal adenocarcinoma (PDAC) remains the most malignant cancer of the pancreas. PDAC constitutes ∼95% of all pancreatic cancers, and it is highly resistant to therapeutics. Th
Autor:
Mostafid, AH, Porta, N, Cresswell, J, Griffiths, TRL, Kelly, JD, Penegar, SR, Davenport, K, McGrath, JS, Campain, N, Cooke, P, Masood, S, Knowles, MA, Feber, A, Knight, A, Catto, JWF, Lewis, R, Hall, E
Publikováno v:
Bju International
Objectives: To evaluate the activity of intravesical mitomycin‐C (MMC) to ablate recurrent low‐risk non‐muscle‐invasive bladder cancer (NMIBC) and assess whether it may enable patients to avoid surgical intervention for treatment of recurrenc
Autor:
Lombardi, B, Ashford, P, Moya-Garcia, AA, Rust, A, Crawford, M, Williams, SV, Knowles, MA, Katan, M, Orengo, C, Godovac-Zimmerman, J
Publikováno v:
Oncotarget
The FGFR3-TACC3 fusion is an oncogenic driver in diverse malignancies, including bladder cancer, characterized by upregulated tyrosine kinase activity. To gain insights into distinct properties of FGFR3-TACC3 down-stream signalling, we utilised telom
Autor:
Pouessel, D, Neuzillet, Y, Mertens, LS, van der Heijden, MS, de Jong, J, Sanders, J, Peters, D, Leroy, K, Manceau, A, Maille, P, Soyeux, P, Moktefi, A, Semprez, F, Vordos, D, de la Taille, A, Hurst, CD, Tomlinson, DC, Harnden, P, Bostrom, PJ, Mirtti, T, Hoernblas, S, Loriot, Y, Houede, N, Chevreau, C, Beuzeboc, P, Shariat, SF, Sagalowsky, AI, Ashfaq, R, Burger, M, Jewett, MAS, Zlotta, AR, Broeks, A, Bapat, B, Knowles, MA, Lotan, Y, van der Kwast, TH, Culine, S, van Rhijn, BWG
Background: Fibroblast growth factor receptor 3 (FGFR3) is an actionable target in bladder cancer. Preclinical studies show that anti-FGFR3 treatment slows down tumor growth, suggesting that this tyrosine kinase receptor is a candidate for personaliz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::b60448bbe6d804ce510f25ba4453dc45
Autor:
Kiemeney, La, Sulem, P, Besenbacher, S, Vermeulen, Sh, Sigurdsson, A, Thorleifsson, G, Stacey, Sn, Gudmundsson, J, Zanon, C, Kostic, J, Bjarnason, H, Palsson, St, Skarpheoinsson, Ob, Gudjonsson, Sa, Witjes, Ja, Grotenhuis, Aj, Vehaegh, Gw, Bishop, Dt, CHUNG SAK, S, Choudhury, A, Elliott, F, Barrett, Jh, Hurst, Cd, DE VERDIER PK, Rudnai, P, Gurzau, E, Koppova, K, Vineis, P, Polidoro, S, Guarrera, S, Sacerdote, C, Campagna, Marcello, Placidi, Donatella, Arici, Cecilia, Zeegers, Mp, Kellen, E, SAEZ GUTIERREZ, B, SANZ VELEZ JI, SANCHEZ ZALABARDO, M, Valdivia, G, GARCIA PRATS MD, Hengstler, Jg, Blaszkewicz, M, Dietrich, H, Ophoff, Ra, VA DEN BERG LH, Aleiusdottir, K, Kristjansson, K, Geirsson, G, Nikulasson, S, Petursdottir, V, Kong, A, Thorgeirsson, T, Mungan, Na, Lindblom, A, VAN ES MA, Porru, Stefano, Buntinx, F, Golka, K, Mayordomo, Ji, Kumar, R, Matullo, G, Steineck, G, Kiltie, Ae, Aben, Kkh, Jonsson, E, Thorsteinsdottir, U, Knowles, Ma, Rafnar, T, Stefansson, K.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::e1cd4a3e644bd5be9f018511b08f45fe
http://hdl.handle.net/11562/956296
http://hdl.handle.net/11562/956296
Publikováno v:
Journal of Pathology; Sep2007, Vol. 213 Issue 1, p91-98, 8p
Publikováno v:
British Journal of Cancer; Feb1996, Vol. 73 Issue 4, p420-423, 4p